Promoting diseases to promote drugs: The role of the pharmaceutical industry in fostering good and bad medicalization
| Autor: | Emilia Kaczmarek |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Pharmacology
Drug Industry Disease mongering business.industry Pain and suffering media_common.quotation_subject Pain Bioethics Public relations 030226 pharmacology & pharmacy 03 medical and health sciences 0302 clinical medicine Pain reduction Medicalization Political science Humans Pharmacology (medical) Grief 030212 general & internal medicine business Pharmaceutical industry media_common Case analysis |
| Zdroj: | British Journal of Clinical Pharmacology. 88:34-39 |
| ISSN: | 1365-2125 0306-5251 |
| DOI: | 10.1111/bcp.14835 |
| Popis: | The pharmaceutical industry and drugs advertisements are sometimes accused of "creating diseases". This article assesses and describes the role of that industry in fostering medicalization. First, the notions of medicalization and pharmaceuticalization are defined. Then, the problem of distinguishing between harmful overmedicalization and well-founded medicalization is presented. Next, the phenomenon of disease mongering is explained and illustrated by the case analysis of medicalizing pain and suffering in three contexts: (1) the general idea of medicalizing physical pain, (2) the medicalization of grief and (3) disease mongering of pseudoaddiction-a condition promoted in order to increase the demand for opioid pain relievers. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text